companydata.dkVesper Bio ApS: Financial statements 2017
CVR: 32879861
Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -2,680,191 compared with DKK -4,003,407 the year before. Equity amounted to DKK 7,885,531. The solvency ratio was 87.8%.
- Profit/Loss
- -2,680,191 kr.
- Equity
- 7,885,531 kr.
- Total Assets
- 8,981,023 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -2.7 mio. | 7.9 mio. | 0 |
| 2016 | - | - | -4 mio. | 3.1 mio. | - |
| 2015 | - | - | -6.1 mio. | 7.1 mio. | - |
| 2014 | - | - | -6.9 mio. | 5.6 mio. | - |
| 2013 | - | - | -2.6 mio. | 12.6 mio. | - |
Find more companies like Vesper Bio ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
As of December 15, 2017, 75PMK Holding ApS is registered as an owner of Vesper Bio ApS with an ownership share of 20%.
Vesper Bio ApS has published its annual report for 2016. The net result was DKK -4,003,407.
About Vesper Bio ApS
Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 3 employees. In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity amounted to DKK -227,433,239.